These jobs with value dossier responsibilities are at pharma companies and specialist health economics consultancies, ranging from Market Access Manager to HEOR Director. The work centres on synthesising clinical, epidemiological and health economic evidence into global value dossiers for HTA processes such as AMNOG and the EU Joint Clinical Assessment. It also includes adapting core dossiers for local reimbursement submissions and integrating economic models to support pricing strategy.
Bologna, Italy. This pivotal global role within the Global Value & Market Access team is responsible for shaping global market access, pricing, evidence-generation, and health policy strategies for Alfasigma’s specialty and rare disease portfolio. The position drives the development of compelling value propositions and evidence plans that support optimal pricing, reimbursement, and patient access outcomes across key global markets. Working … Lees meer
Raleigh, NC, VS. We zijn op zoek naar een zeer gemotiveerde en gedetailleerd ingestelde stagiair die ons team voor Medische en Wetenschappelijke Zaken en Marktkansen wil versterken. Deze stage biedt een unieke kans om praktische ervaring op te doen in de strategische en operationele aspecten van marktkansen binnen een toonaangevend bedrijf in de life sciences. De stagiair zal bijdragen aan initiatieven die ervoor zorgen dat patiënten optimaal toegang hebben tot innovatieve … Lees meer
Remote, US. At iRhythm, you’ll have the opportunity to grow your skills and your career while impacting the lives of people around the world. iRhythm is shaping a future where everyone, everywhere can access the best possible cardiac health solutions. Every day, we collaborate, create, and constantly reimagine what’s possible. We think big and move fast, driven by our commitment … Lees meer
Hyderabad, India. The Global HEOR Value Writing Senior Associate plays a critical role in supporting Amgen’s global market access strategy through high-quality Health Technology Assessment (HTA) deliverables. This role collaborates closely with team lead and Global HEOR Product Leads to ensure alignment with product strategy. The Value Writing Senior Associate develops Global Value Dossiers (GVDs), US AMCP dossiers, EU JCA … Lees meer
Cambridge, MA, VS. De directeur van US gezondheidseconomie and Outcomes Research (HEOR) & Real World Evidence (RWE) is verantwoordelijk voor het identificeren van real-world en economische evidencebehoeften en het ontwikkelen van de real-world, klinische, humanistische en economische evidence-generation plannen in samenwerking met interne businesspartners om de waarde van onze producten voor Amerikaanse zorgverleners, besluitvormers in de volksgezondheidssector en andere externe stakeholders te ondersteunen … Lees meer
KRIJG TOEGANG TOT 100% MET PRo
Gratis toegang stoppen hier
Je ziet slechts 30% rollen, met een vertraging van 7 dagen. Met Pro krijg je er nu meteen 100% te zien. 365 openstaande rollen voor Pro-leden vandaag.
These jobs with value dossier responsibilities are at pharma companies and specialist health economics consultancies, ranging from Market Access Manager to HEOR Director. The work centres on synthesising clinical, epidemiological and health economic evidence into global value dossiers for HTA processes such as AMNOG and the EU Joint Clinical Assessment. It also includes adapting core dossiers for local reimbursement submissions and integrating economic models to support pricing strategy.
Wij hechten waarde aan uw privacy. We gebruiken cookies om uw ervaring op onze website te verbeteren, inhoud en advertenties te personaliseren en ons verkeer te analyseren. U kunt kiezen welke cookies u toestaat en u kunt uw toestemming op elk gewenst moment intrekken. Zie voor meer informatie onze Cookiebeleid.
These jobs with value dossier responsibilities are at pharma companies and specialist health economics consultancies, ranging from Market Access Manager to HEOR Director. The work centres on synthesising clinical, epidemiological and health economic evidence into global value dossiers for HTA processes such as AMNOG and the EU Joint Clinical Assessment. It also includes adapting core dossiers for local reimbursement submissions and integrating economic models to support pricing strategy.
